Have a feature idea you'd love to see implemented?
Let us know!
MEIP MEI Pharma Inc
Price (delayed)
$2.81
Market cap
$18.72M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.99
Enterprise value
$11.77M
MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma's portfolio of drug candidates contains four clinical-stage assets, including zandelisib, currently in
Highlights
MEI Pharma's debt has shrunk by 100% YoY
The company's quick ratio has surged by 104% QoQ but it fell by 2.4% YoY
MEI Pharma's gross profit has shrunk by 100% QoQ and by 100% YoY
MEIP's revenue has shrunk by 100% QoQ and by 100% YoY
Key stats
What are the main financial stats of MEIP
Market
Valuations
Earnings
Shares outstanding
6.66M
Market cap
$18.72M
Enterprise value
$11.77M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.75
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$46.6M
EBITDA
-$43.66M
Free cash flow
-$43.43M
Per share
Balance sheet
Liquidity
EPS
-$6.99
Free cash flow per share
-$6.52
Book value per share
$3.73
Revenue per share
$0
TBVPS
$4.16
Total assets
$27.75M
Total liabilities
$2.87M
Debt
$0
Equity
$24.88M
Working capital
$24.87M
Debt to equity
0
Current ratio
9.66
Quick ratio
9.37
Net debt/EBITDA
0.16
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-85.1%
Return on equity
-110.7%
Return on invested capital
-95.3%
Return on capital employed
-187.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MEIP stock price
How has the MEI Pharma stock price performed over time
Intraday
0.36%
1 week
-6.64%
1 month
2.55%
1 year
-53.01%
YTD
-51.55%
QTD
-1.4%
Financial performance
How have MEI Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$49.09M
Net income
-$46.6M
Gross margin
N/A
Net margin
N/A
MEI Pharma's gross profit has shrunk by 100% QoQ and by 100% YoY
MEIP's revenue has shrunk by 100% QoQ and by 100% YoY
Growth
What is MEI Pharma's growth rate over time
Valuation
What is MEI Pharma stock price valuation
P/E
N/A
P/B
0.75
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The stock's price to book (P/B) is 74% less than its 5-year quarterly average of 2.9 but 25% more than its last 4 quarters average of 0.6
The equity has shrunk by 69% YoY and by 25% QoQ
MEIP's revenue has shrunk by 100% QoQ and by 100% YoY
Efficiency
How efficient is MEI Pharma business performance
Dividends
What is MEIP's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did MEI Pharma financials performed over time
The company's quick ratio has surged by 104% QoQ but it fell by 2.4% YoY
MEI Pharma's current ratio has surged by 98% QoQ but it has decreased by 6% YoY
MEI Pharma's debt is 100% lower than its equity
MEI Pharma's debt has shrunk by 100% YoY
MEI Pharma's debt to equity has shrunk by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.